Gastrointestinal hormones, intestinal microbiota and metabolic homeostasis in obese patients: Effect of bariatric surgery

In Vivo

Volumn 30, Issue 3, 2016, Pages 321-330

  Federico, Alessandro ^a   Dallio, Marcello ^a   Tolone, Salvatore ^a   Gravina, Antonietta Gerarda ^a   Patrone, Vania ^b   Romano, Marco ^a   Tuccillo, Concetta ^a   Mozzillo, Anna Licia ^a   Amoroso, Vincenzo ^a   Misso, Gabriella ^a   Morelli, Lorenzo ^b   Docimo, Ludovico ^a   Loguercio, Carmelina ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Bariatric surgery; Diabetes; Gastrointestinal hormones; Gut microbiota; Obesity

Indexed keywords

ALPHA TOCOPHEROL; AMIDE; ASCORBIC ACID; CALCIUM; CARBOHYDRATE; CHOLECYSTOKININ; CHOLESTEROL; FOLIC ACID; GASTROINTESTINAL HORMONE; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; IRON; LIPID; MONOUNSATURATED FATTY ACID; NICOTINIC ACID; OREXIN; PEPTIDE YY; POLYUNSATURATED FATTY ACID; PROTEIN; PYRIDOXINE; RETINOL; RIBOFLAVIN; SATURATED FATTY ACID; THIAMINE; VITAMIN D; ZINC;

ADULT; ARTICLE; BACTERIAL STRAIN; BARIATRIC SURGERY; BODY COMPOSITION; BODY WEIGHT; CHOLECYSTOJEJUNAL ANASTOMOSIS; CHOLECYSTOTOMY; CLINICAL ARTICLE; CLOSTRIDIA; CONTROLLED STUDY; DIETARY INTAKE; FECES MICROFLORA; FEMALE; FOOD INTAKE; HOMEOSTASIS; HUMAN; INTESTINE FLORA; JEJUNOILEOSTOMY; LACTOBACILLUS CRISPATUS; MALE; MEGASPHAERA ELSDENII; METABOLISM; MICROBIAL COMMUNITY; MIDDLE AGED; MORBID OBESITY; NUTRIENT; NUTRITIONAL ASSESSMENT; PLASMA; PROTEIN BLOOD LEVEL; SIDE TO SIDE ANASTOMOSIS; BLOOD; BODY MASS; ENERGY METABOLISM; FECES; MICROBIOLOGY; OBESITY; OBESITY, MORBID; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BARIATRIC SURGERY; BODY MASS INDEX; CHOLECYSTOKININ; ENERGY METABOLISM; FECES; FEMALE; GASTROINTESTINAL HORMONES; GASTROINTESTINAL MICROBIOME; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; OBESITY; OBESITY, MORBID; OREXINS; PEPTIDE YY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85016075526     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Dockray GJ: Gut endocrine secretions and their relevance to satiety. Curr Opin Pharmacol 4: 557-560, 2004.
2. Capasso R and Izzo AA: Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. J Neuroendocrinol 20: 39-46, 2008.
3. Woods SC: Signals that influence food intake and body weight. Physiol Behav 86: 709-716, 2005.
4. Blundell JE: Perspective on the central control of appetite. Obesity 14: 160-163, 2006.
5. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A and Leitzmann MF: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355: 763-778, 2006.
6. Colquitt JL, Picot J, Loveman E and Clegg AJ: Surgery for obesity. Cochrane Database Syst Rev (2): CD003641, 2009.
7. Ling H, Lenz TL, Burns TL and Hilleman DE: Reducing the risk of obesity: defining the role of weight loss drugs. Pharmacotherapy 33: 1308-1321, 2013.
8. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H and Swedish Obese Subjects Study Scientific Group: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: 2683-2693, 2004.
9. Murphy EF and Quigley EM: The microbiota and bariatric surgery: it's a bug's life. Gastroenterology 142: 399-401, 2012.
10. Ley RE, Turnbaugh PJ, Klein S and Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023, 2006.
11. Angelakis E, Armougom F, Million M and Raoult D: The relationship between gut microbiota and weight gain in humans. Future Microbiol 7: 91-109, 2012.
12. Backhed F, Ley RE, Sonnenburg JL, Peterson DA and Gordon JI: Host-bacterial mutualismin the human intestine. Science 307: 1915-1920, 2005.
13. Li JV, Ashrafian H, Bueter M, Kinross J, Sands C, le Roux CW, Bloom SR, Darzi A, Athanasiou T, Marchesi JR, Nicholson JK and Holmes E: Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut 60: 1214-1223, 2011.
14. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE and Krajmalnik-Brown R: Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106: 2365-2370, 2009.
15. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, Mariat D, Corthier G, Doré J, Henegar C, Rizkalla S and Clément K: Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes 59: 3049-3057, 2010.
16. Liou AP, Paziuk M, Luevano JM Jr., Machineni S, Turnbaugh PJ and Kaplan LM: Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 5: 178ra41, 2013.
17. Cani PD and Delzenne NM: Benefits of bariatric surgery: an issue of microbialehost metabolism interactions? Gut 60: 1166-1167, 2011.
18. Pournaras DJ, Osborne A, Hawkins SC, Mahon D, Ghatei MA, Bloom SR, Welbourn R and le Roux CW: The Gut Hormone Response Following Roux-en-Y Gastric Bypass: Cross-sectional and Prospective Study. Obes Surg 20: 56-60, 2010.
19. Wallace TM, Levy JC and Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495, 2004.
20. http://www.sinu.it/html/pag/tabelle-larn-2014-rev.asp
21. Babor TF, De La Fuente JR, Saunders J and Grant M: The alcohol use disorders identification test: guidelines for use in primary health care. Geneva: World Health Organization AUDIT, 1989.
22. Loguercio C, Di Pierro M, Di Marino MP, Federico A, Disalvo D, Crafa E, Tuccillo C, Baldi F and del VecchioBlanco C: Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects. Alcohol Alcohol 35: 296-301, 2000.
23. Eriksson F: Biliointestinal bypass. Int J Obes 14: 47-55, 1990.
24. Russo V, Ammendola E, De Crescenzo I, Ricciardi D, Capuano P, Topatino A, Docimo L, Santangelo L and Calabró R: Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. Obes Surg 17: 857-865, 2007.
25. Walter J, Tannock GW, Tilsala-Timisjarvi A, Rodtong S, Loach DM, Munro K and Alatossava T: Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers. Appl Environ Microbiol 66: 297-303, 2000.
26. Patrone V, Ferrari S, Lizier M, Lizier M, Lucchini F, Minuti A, Tondelli B, Trevisi E, Rossi F and Callegari ML: Short-term modifications in the distal gut microbiota of weaning mice induced by a high-fat diet. Microbiology 158: 983-992, 2012.
27. Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, Barinas-Mitchell E, Eid GM, Ramanathan R, Taylor DS and Schauer PR: Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242: 610-617, 2005.
28. Holst JJ, Vilsboll T and Deacon CF: The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297: 127-136, 2009.
29. Rask E, Olsson T, Söderberg S, Johnson O, Seckl J, Holst JJ, Ahrén B and Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA): Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care 24: 1640-1645, 2001.
30. Thomas S and Schauer P: Bariatric surgery and the gut hormone response. Nutr Clin Pract 25: 175-182, 2010.
31. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L and Kelley D: Effect of laparoscopic Rouxen Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238: 467-484, 2003.
32. Philippe J: Role and indication of GLP-1 analogues in the treatment of type 2 diabetes. Rev Med Suisse 5: 1260-1262, 2009.
33. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC and Shekelle PG: Meta-Analysis: surgical treatment of obesity. Ann Intern Med 142: 547-559, 2005.
34. Rubino F, Schauer PR, Kaplan LM and Cummings DE: Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev 61: 393-411, 2010.
35. Angrisani L, Lorenzo M and Borrelli V: Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 3: 127-132, 2007.
36. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J and Diamond E: The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240: 236-242, 2004.
37. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M and Marescaux J: The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244: 741-749, 2006.
38. Ponce J, Haynes B, Paynter S, Fromm R, Lindsey N, Shafer A, Manahan E and Sutterfield C: Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg 14: 1335-1342, 2004.
39. Le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG and Bloom SR: Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243: 108-114, 2006.
40. Holst JJ: The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439, 2007.
41. Meier JJ, Gallwitz B, Salmen S, Goetze O, Holst JJ, Schmidt WE and Nauck MA: Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88: 2719-2725, 2003.
42. Sclafani A, Ackroff K and Abumrad NA: CD36 gene deletion reduces fat preference and intake but not postoral fat conditioning in mice. Am J Physiol Regul Integr Comp Physiol 293: 1823-1832, 2007.
43. Karamanakos SN, Vagenas K, Kalfarentzos F and Alexandrides TK: Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 247: 401-407, 2008.
44. Pournaras DJ, Osborne A, Hawkins SC, Mahon D, Ghatei MA, Bloom SR, Welbourn R and le Roux CW: The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study. Obes Surg 20: 56-60, 2010.
45. Peterli R, Wölnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, von Flüe M and Beglinger C: Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250: 234-241, 2009.
46. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
47. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP and Purnell JQ: Plasma ghrelin levels after dietinduced weight loss or gastric bypass surgery. N Engl J Med 346: 1623-1630, 2002.
48. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA and Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141: 4325-4328, 2000.
49. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA and Kasuga M: Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337-345, 2001.
50. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Goldstein JL and Brown MS: Ghrelin O-Acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci USA 107: 7467-7472, 2010.
51. Tschop M, Smiley DL and Heiman ML: Ghrelin induces adiposity in rodents. Nature 407: 908-913, 2000.
52. Ramón JM, Salvans S, Crous X, Puig S, Goday A, Benaiges D, Trillo L, Pera M and Grande L: Effect of Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy on Glucose and Gut Hormones: a Prospective Randomised Trial. J Gastrointest Surg 16: 1116-1122, 2012.
53. Niswender K: Diabetes and obesity: therapeutic targeting and risk reduction-A complex interplay. Diabetes Obes Metab 12: 267-287, 2010.
54. Dixon JB, Bhathal PS, Hughes NR and O'Brien PE: Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39: 1647-1654, 2004.
55. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER and Gordon JI: An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031, 2006.
56. Shetty SA, Marathe NP, Lanjekar V, Ranade D and Shouche YS: Comparative Genome Analysis of Megasphaera sp. Reveals Niche Specialization and Its Potential Role in the Human Gut. PLoS One 8: e79353, 2013.
57. Lin HV, Frassetto A, Kowalik EJ Jr., Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G and Marsh DJ: Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 7: e35240, 2012.
58. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F and Gribble FM: Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61: 364-371, 2012.
59. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M and Keenan MJ: Dietary resistant starch up-regulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 295: 1160-1166, 2008.
60. Wu T, Zhao BR, Bound MJ, Checklin HL, Bellon M, Little TJ, Young RL, Jones KL, Horowitz M and Rayner CK: Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans. Am J Clin Nutr 95: 78-83, 2012.